Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.

Georg Hopfinger; Thomas Nösslinger; Alois Lang; Werner Linkesch; Thomas Melchardt; Lukas Weiss; Alexander Egle; Richard Greil

doi:10.1007/s00277-014-2009-0

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.

Georg Hopfinger^* (First author)
, Thomas Nösslinger
, Alois Lang
, Werner Linkesch
, Thomas Melchardt (Co-author)
, Lukas Weiss (Co-author)
, Alexander Egle (Co-author)
, Richard Greil (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

46 Citations (Web of Science)

Original language	English
Pages (from-to)	459-462
Journal	ANNALS OF HEMATOLOGY
Volume	93
Issue number	3
DOIs	https://doi.org/10.1007/s00277-014-2009-0
Publication status	Published - 2014

Keywords

NON-HODGKIN-LYMPHOMA
MULTICENTER

Access to Document

10.1007/s00277-014-2009-0

Cite this

Hopfinger, G., Nösslinger, T., Lang, A., Linkesch, W., Melchardt, T., Weiss, L., Egle, A., & Greil, R. (2014). Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. ANNALS OF HEMATOLOGY , 93(3), 459-462. https://doi.org/10.1007/s00277-014-2009-0

Hopfinger, Georg ; Nösslinger, Thomas ; Lang, Alois et al. / Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. In: ANNALS OF HEMATOLOGY 2014 ; Vol. 93, No. 3. pp. 459-462.

@article{5127f0f002d243a5953111338e17cd77,

title = "Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.",

keywords = "NON-HODGKIN-LYMPHOMA, MULTICENTER",

author = "Georg Hopfinger and Thomas N{\"o}sslinger and Alois Lang and Werner Linkesch and Thomas Melchardt and Lukas Weiss and Alexander Egle and Richard Greil",

note = "G. Hopfinger (*): T. Melchardt: L. Weiss: A. Egle: R. Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Salzburger Landeskliniken, Paracelsus Medical University Salzburg, M{\"u}llner Hauptstrasse 48, 5020 Salzburg, Austria",

year = "2014",

doi = "10.1007/s00277-014-2009-0",

language = "English",

volume = "93",

pages = "459--462",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

publisher = "Springer Nature",

number = "3",

}

Hopfinger, G, Nösslinger, T, Lang, A, Linkesch, W, Melchardt, T , Weiss, L , Egle, A & Greil, R 2014, 'Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.', ANNALS OF HEMATOLOGY , vol. 93, no. 3, pp. 459-462. https://doi.org/10.1007/s00277-014-2009-0

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. / Hopfinger, Georg (First author); Nösslinger, Thomas; Lang, Alois et al.
In: ANNALS OF HEMATOLOGY , Vol. 93, No. 3, 2014, p. 459-462.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.

AU - Hopfinger, Georg

AU - Nösslinger, Thomas

AU - Lang, Alois

AU - Linkesch, Werner

AU - Melchardt, Thomas

AU - Weiss, Lukas

AU - Egle, Alexander

AU - Greil, Richard

N1 - G. Hopfinger (*): T. Melchardt: L. Weiss: A. Egle: R. Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Salzburger Landeskliniken, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020 Salzburg, Austria

PY - 2014

Y1 - 2014

KW - NON-HODGKIN-LYMPHOMA

KW - MULTICENTER

U2 - 10.1007/s00277-014-2009-0

DO - 10.1007/s00277-014-2009-0

M3 - Original Article

C2 - 24441915

SN - 0939-5555

VL - 93

SP - 459

EP - 462

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

IS - 3

ER -

Hopfinger G, Nösslinger T, Lang A, Linkesch W, Melchardt T , Weiss L et al. Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. ANNALS OF HEMATOLOGY . 2014;93(3):459-462. doi: 10.1007/s00277-014-2009-0